Mutual Advisors’s Medifast MED Stock Holding History

Mutual Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,202	Closed	-$205K	–	902
2022 Q1	$205K	Sell	1,202 -444	-27%	-$83.7K	0.01%	821
2021 Q4	$345K	Buy	1,646 +10	+0.6%	+$2.07K	0.02%	688
2021 Q3	$315K	Buy	1,636 +9	+0.6%	+$2.21K	0.02%	702
2021 Q2	$461K	Sell	1,627 -101	-6%	-$27.4K	0.03%	552
2021 Q1	$366K	Sell	1,728 -181	-9%	-$43.3K	0.03%	577
2020 Q4	$375K	Sell	1,909 -7	-0.4%	-$1.24K	0.03%	541
2020 Q3	$315K	Buy	1,916 +20	+1%	+$3.29K	0.03%	529
2020 Q2	$263K	Buy	+1,896	New	+$174K	0.03%	532
2018 Q4	–	Sell	-3,043	Closed	-$674K	–	470
2018 Q3	$674K	Buy	3,043 +122	+4%	+$24.7K	0.1%	235
2018 Q2	$468K	Buy	2,921 +82	+3%	+$10.5K	0.11%	255
2018 Q1	$265K	Buy	+2,839	New	+$212K	0.07%	337

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Mutual Advisors's MED Position: Q2 2022 in Review

Mutual Advisors sold out of Medifast (MED) in Q2 2022, closing a stake of 1,202 shares — an estimated $205K sold.

Mutual Advisors first reported a position in MED in Q1 2018 and held it in 11 quarters. The position peaked at $674K in Q3 2018. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Mutual Advisors reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Mutual Advisors sold 1,202 Medifast shares in Q2 2022, an estimated $205K.
Mutual Advisors first reported a position in Medifast in Q1 2018 and held it in 11 quarters.
Mutual Advisors's Medifast position peaked at $674K in Q3 2018.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Mutual Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.